Peginterferon alfa-2b Interactions
There are 227 drugs known to interact with peginterferon alfa-2b, along with 20 disease interactions. Of the total drug interactions, 41 are major, 182 are moderate, and 4 are minor.
- View all 227 medications that may interact with peginterferon alfa-2b
- View peginterferon alfa-2b disease interactions (20)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2b and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Adderall (amphetamine / dextroamphetamine)
- Aleve (naproxen)
- Ativan (lorazepam)
- Avelox (moxifloxacin)
- Avodart (dutasteride)
- Benadryl (diphenhydramine)
- Chantix (varenicline)
- Claritin (loratadine)
- Concerta (methylphenidate)
- Diovan (valsartan)
- Effexor XR (venlafaxine)
- Flexeril (cyclobenzaprine)
- Haldol Decanoate (haloperidol)
- Hycodan (homatropine / hydrocodone)
- Imodium (loperamide)
- Incivek (telaprevir)
- Indium In-111 DTPA (indium pentetate in-111)
- Klor-Con (potassium chloride)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Morphine Sulfate ER (morphine)
- MSIR (morphine)
- Naftin (naftifine topical)
- Nasonex (mometasone nasal)
- Neurontin (gabapentin)
- Nexium (esomeprazole)
- Niaspan (niacin)
- Symbicort (budesonide / formoterol)
- Zoloft (sertraline)
Peginterferon alfa-2b disease interactions
There are 20 disease interactions with peginterferon alfa-2b which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
Report options
More about peginterferon alfa-2b
- peginterferon alfa-2b consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Atezolizumab
Atezolizumab (Tecentriq) is a type of immunotherapy drug that helps the body's immune system to ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.